Literature DB >> 12065645

PI 3-kinase regulation of dopamine uptake.

Lucia Carvelli1, José A Morón, Kristopher M Kahlig, Jasmine V Ferrer, Namita Sen, James D Lechleiter, L M Fredrik Leeb-Lundberg, Gerald Merrill, Eileen M Lafer, Lisa M Ballou, Toni S Shippenberg, Jonathan A Javitch, Richard Z Lin, Aurelio Galli.   

Abstract

The magnitude and duration of dopamine (DA) signaling is defined by the amount of vesicular release, DA receptor sensitivity, and the efficiency of DA clearance, which is largely determined by the DA transporter (DAT). DAT uptake capacity is determined by the number of functional transporters on the cell surface as well as by their turnover rate. Here we show that inhibition of phosphatidylinositol (PI) 3-kinase with LY294002 induces internalization of the human DAT (hDAT), thereby reducing transport capacity. Acute treatment with LY294002 reduced the maximal rate of [(3) H]DA uptake in rat striatal synaptosomes and in human embryonic kidney (HEK) 293 cells stably expressing the hDAT (hDAT cells). In addition, LY294002 caused a significant redistribution of the hDAT from the plasma membrane to the cytosol. Conversely, insulin, which activates PI 3-kinase, increased [(3)H]DA uptake and blocked the amphetamine-induced hDAT intracellular accumulation, as did transient expression of constitutively active PI 3-kinase. The LY294002-induced reduction in [(3)H]DA uptake and hDAT cell surface expression was inhibited by expression of a dominant negative mutant of dynamin I, indicating that dynamin-dependent trafficking can modulate transport capacity. These data implicate DAT trafficking in the hormonal regulation of dopaminergic signaling, and suggest that a state of chronic hypoinsulinemia, such as in diabetes, may alter synaptic DA signaling by reducing the available cell surface DATs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065645     DOI: 10.1046/j.1471-4159.2002.00892.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  77 in total

1.  Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.

Authors:  Kathrine R Weeks; Donard S Dwyer; Eric J Aamodt
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

2.  Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Authors:  Sabrina D Robertson; Heinrich J G Matthies; W Anthony Owens; Vidiya Sathananthan; Nicole S Bibus Christianson; J Phillip Kennedy; Craig W Lindsley; Lynette C Daws; Aurelio Galli
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

3.  Cracking the moody brain: the rewards of self starvation.

Authors:  Caroline F Zink; Daniel R Weinberger
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

4.  Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression.

Authors:  Nicole K Speed; Heinrich J G Matthies; J Phillip Kennedy; Roxanne A Vaughan; Jonathan A Javitch; Scott J Russo; Craig W Lindsley; Kevin Niswender; Aurelio Galli
Journal:  ACS Chem Neurosci       Date:  2010-05-25       Impact factor: 4.418

Review 5.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

6.  Common variations in 4p locus are related to male completed suicide.

Authors:  Anne Must; Sulev Kõks; Eero Vasar; Gunnar Tasa; Aavo Lang; Eduard Maron; Marika Väli
Journal:  Neuromolecular Med       Date:  2008-12-25       Impact factor: 3.843

7.  Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.

Authors:  J L Harenza; P P Muldoon; M De Biasi; M I Damaj; M F Miles
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  The clathrin-dependent localization of dopamine transporter to surface membranes is affected by α-synuclein.

Authors:  Haya Kisos; Tziona Ben-Gedalya; Ronit Sharon
Journal:  J Mol Neurosci       Date:  2013-09-19       Impact factor: 3.444

10.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.